FULC
Price
$5.41
Change
+$0.34 (+6.71%)
Updated
May 8 closing price
Capitalization
292.03M
89 days until earnings call
SGMO
Price
$0.72
Change
+$0.07 (+10.77%)
Updated
May 8 closing price
Capitalization
149.07M
3 days until earnings call
Ad is loading...

FULC vs SGMO

Header iconFULC vs SGMO Comparison
Open Charts FULC vs SGMOBanner chart's image
Fulcrum Therapeutics
Price$5.41
Change+$0.34 (+6.71%)
Volume$440.33K
Capitalization292.03M
Sangamo Therapeutics
Price$0.72
Change+$0.07 (+10.77%)
Volume$3.87M
Capitalization149.07M
FULC vs SGMO Comparison Chart
Loading...
FULC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SGMO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
FULC vs. SGMO commentary
May 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FULC is a StrongBuy and SGMO is a Hold.

Ad is loading...
COMPARISON
Comparison
May 09, 2025
Stock price -- (FULC: $5.41 vs. SGMO: $0.72)
Brand notoriety: FULC and SGMO are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: FULC: 83% vs. SGMO: 51%
Market capitalization -- FULC: $292.03M vs. SGMO: $149.07M
FULC [@Biotechnology] is valued at $292.03M. SGMO’s [@Biotechnology] market capitalization is $149.07M. The market cap for tickers in the [@Biotechnology] industry ranges from $301.75B to $0. The average market capitalization across the [@Biotechnology] industry is $2.17B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

FULC’s FA Score shows that 1 FA rating(s) are green whileSGMO’s FA Score has 0 green FA rating(s).

  • FULC’s FA Score: 1 green, 4 red.
  • SGMO’s FA Score: 0 green, 5 red.
According to our system of comparison, FULC is a better buy in the long-term than SGMO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

FULC’s TA Score shows that 6 TA indicator(s) are bullish while SGMO’s TA Score has 4 bullish TA indicator(s).

  • FULC’s TA Score: 6 bullish, 4 bearish.
  • SGMO’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, FULC is a better buy in the short-term than SGMO.

Price Growth

FULC (@Biotechnology) experienced а +23.52% price change this week, while SGMO (@Biotechnology) price change was -2.89% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -3.66%. For the same industry, the average monthly price growth was +15.23%, and the average quarterly price growth was -12.40%.

Reported Earning Dates

FULC is expected to report earnings on Aug 06, 2025.

SGMO is expected to report earnings on Aug 12, 2025.

Industries' Descriptions

@Biotechnology (-3.66% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
FULC($292M) has a higher market cap than SGMO($149M). FULC YTD gains are higher at: 15.106 vs. SGMO (-29.431). FULC has higher annual earnings (EBITDA): -18.24M vs. SGMO (-123.99M). FULC has more cash in the bank: 241M vs. SGMO (39.2M). FULC has less debt than SGMO: FULC (8.63M) vs SGMO (27.7M). FULC has higher revenues than SGMO: FULC (80M) vs SGMO (52.3M).
FULCSGMOFULC / SGMO
Capitalization292M149M196%
EBITDA-18.24M-123.99M15%
Gain YTD15.106-29.431-51%
P/E RatioN/AN/A-
Revenue80M52.3M153%
Total Cash241M39.2M615%
Total Debt8.63M27.7M31%
FUNDAMENTALS RATINGS
FULC vs SGMO: Fundamental Ratings
FULC
SGMO
OUTLOOK RATING
1..100
2965
VALUATION
overvalued / fair valued / undervalued
1..100
27
Undervalued
58
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9096
PRICE GROWTH RATING
1..100
3565
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

FULC's Valuation (27) in the null industry is in the same range as SGMO (58) in the Biotechnology industry. This means that FULC’s stock grew similarly to SGMO’s over the last 12 months.

FULC's Profit vs Risk Rating (100) in the null industry is in the same range as SGMO (100) in the Biotechnology industry. This means that FULC’s stock grew similarly to SGMO’s over the last 12 months.

FULC's SMR Rating (90) in the null industry is in the same range as SGMO (96) in the Biotechnology industry. This means that FULC’s stock grew similarly to SGMO’s over the last 12 months.

FULC's Price Growth Rating (35) in the null industry is in the same range as SGMO (65) in the Biotechnology industry. This means that FULC’s stock grew similarly to SGMO’s over the last 12 months.

FULC's P/E Growth Rating (100) in the null industry is in the same range as SGMO (100) in the Biotechnology industry. This means that FULC’s stock grew similarly to SGMO’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
FULCSGMO
RSI
ODDS (%)
Bearish Trend 1 day ago
77%
Bullish Trend 4 days ago
76%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
85%
Bullish Trend 2 days ago
78%
Momentum
ODDS (%)
Bullish Trend 1 day ago
87%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bullish Trend 1 day ago
84%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
86%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
86%
Bearish Trend 2 days ago
89%
Advances
ODDS (%)
Bullish Trend 4 days ago
86%
Bullish Trend 17 days ago
76%
Declines
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 3 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
75%
Bullish Trend 2 days ago
82%
Aroon
ODDS (%)
Bullish Trend 1 day ago
87%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Ad is loading...
FULC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SGMO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PFSAX22.82N/A
N/A
PGIM Jennison Financial Services A
ESAGX10.86N/A
N/A
Ashmore Emerging Markets Equity ESG A
GISOX16.91N/A
N/A
Grandeur Peak Intl Stalwarts Inv
LAFTX18.75N/A
N/A
Lord Abbett Affiliated R5
HFEAX53.26-0.06
-0.11%
Janus Henderson European Focus A

FULC and

Correlation & Price change

A.I.dvisor indicates that over the last year, FULC has been loosely correlated with SLS. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if FULC jumps, then SLS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To FULC
1D Price
Change %
FULC100%
+6.71%
SLS - FULC
48%
Loosely correlated
-1.75%
ANNX - FULC
40%
Loosely correlated
+0.59%
VRDN - FULC
39%
Loosely correlated
+3.99%
NKTX - FULC
36%
Loosely correlated
+4.28%
MLTX - FULC
34%
Loosely correlated
+5.69%
More